Myopia
Conditions
Keywords
Myopia, children, teenagers, atropine, lunettes, contact lenses, combinations
Brief summary
The prevalence of myopia and its complications has risen considerably in recent decades, particularly among children and teenagers. This trend is also spreading in Europe, driven by the increase in screen time and the intensive use of new technologies and social media, particularly among the younger generation. Several treatment options are available today, including pharmacological treatments with atropine eye drops, as well as optical myopia control systems in the form of glasses or contact lenses. These different treatments have been used in clinical practice at Saint-Étienne University Hospital since 2017 for atropine, and more recently with the development of optical myopia control systems and their combinations. Little clinical data has been published to date on these different treatment combinations in the French population. The investigators would therefore like to set up a database to publish their results and share their experience.
Interventions
OTHERDemographic data collection
Demographic data collection: age, gender, level of education/study, time spent in near vision, sports practice, medical history
OTHEROphthalmological history
Ophthalmological history: age of myopia discovery, parental refraction, previous refractions, presence of a braking treatment
OTHEROphthalmological data at each examination
Ophthalmological data at each examination: visual acuity, subjective refraction, cycloplegia with SKIACOL, axial length.
OTHERPotential adverse events
Potential adverse events: halos, photophobia, stinging, infections, etc.
Sponsors
Centre Hospitalier Universitaire de Saint Etienne
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
No minimum to 25 Years
Healthy volunteers
No
Inclusion criteria
* Children or young adults with active myopia treated with ATROPINE 0.01% eye drops or myopia control glasses or contact lenses, and their various combinations * patient affiliated with a social security organization * agreement of both parents or the patient if adult
Exclusion criteria
\- non compliance with treatment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Database of active treatments for myopia | Month 5 | Database established with data from children or young adults with active myopia treated with ATROPINE 0.01% eye drops or myopia control spectacles or contact lenses, and their various combinations. |
Countries
France
Outcome results
None listed